MARATTO

article · Inflammopharmacology

Repurposing of high-dose N-acetylcysteine as anti-inflammatory, antioxidant and neuroprotective  agent  in moderate to severe traumatic brain injury patients: a randomized controlled trial

20253 citationsOpen accessAlexandria University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Pactr.org identifier: (PACTR202209548995270) on 14 September 2022.

Research topics

  • S100 Proteins and Annexins
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Anesthesia and Neurotoxicity Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1007/s10787-025-01706-0

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.